相关实验视频
Updated: Feb 10, 2026

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
17.0K
准循环FABP4改善了与肥胖相关的肝硬化症
bioRxiv : the preprint server for biology
|February 9, 2026
概括
来自脂肪细胞的脂肪酸结合蛋白4 (FABP4) 在肥胖中驱动肝脏脂肪的积累. 通过抗体中和FABP4,可以减少这种肝脏肥胖症,从而提供了一个新的治疗点.
科学领域:
- 代谢性疾病研究研究.
- 肝病学 肝病学是一种肝病学.
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 肥胖是肝硬化 (脂肪肝疾病) 的首要原因之一.
- 连接肥胖与肝脂积累的精确分子机制尚未完全理解.
- 脂肪酸结合蛋白4 (FABP4) 参与脂质代谢,但其在肥胖驱动性肝肥胖症中的作用需要澄清.
研究的目的:
- 调查循环FABP4在调解脂肪细胞和肝细胞之间脂质交叉的作用.
- 为了确定FABP4是否是肥胖相关的肝硬化症的潜在治疗标.
主要方法:
- 对人类肝脏组织和肥胖和肥胖症的小鼠模型的分析.
- 特别是在脂肪细胞中,FABP4的遗传删除.
- 在肥胖小鼠模型中开发和测试一个中和的抗FABP4单克隆抗体.
主要成果:
- 在肥胖症期间,FABP4蛋白,而不是其转录,会在肝细胞中积累,这表明存在外部来源.
- 脂肪细胞特异性FABP4的删除可以预防饮食诱导的肝肥胖症,而不会影响整体肥胖或全身脂质水平.
- 循环中的FABP4直接与肝细胞结合,增强自由脂肪酸的吸收.
- 在多个模型中,用抗FABP4抗体治疗减少了FABP4的结合,抑制了脂肪酸的摄取,并减弱了肝硬化症.
结论:
- 循环中的FABP4通过促进肝细胞脂质吸收,作为关键的调解者,将脂肪与肝硬化联系起来.
- 中和FABP4为管理与肥胖相关的脂肪肝疾病提供了一个有前途的治疗策略.
更多相关视频
相关概念视频
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Coronary Circulation
7.4K
The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.4K
Fetal Circulation
3.1K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
3.1K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System
6.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.1K
Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269

